Do Wall Street Analysts Like HCA Healthcare Stock? The recent Q2 performance of HCA Healthcare, Inc.
has been touted as a success story by some, but a closer look at the numbers reveals ongoing challenges in convincing Wall Street. Revenue climbed 8. 7% year over year to $20.
23 billion, and adjusted earnings per share (EPS) rose 11% to $7. 59. However, these gains are tempered by a full year outlook revision that reflects industry pressures.